Literature DB >> 9434946

Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function.

V Geoffroy1, D A Corral, L Zhou, B Lee, G Karsenty.   

Abstract

The Cbfa1 gene, which encodes the transcription factor Osf2/Cbfa1 required for osteoblast differentiation in mouse and human, is mutated in cleidocranial dysplasia, a skeletal dysplasia. We describe here the isolation of the full-length human OSF2/CBFA1 cDNAs, the genomic organization of the entire CBFA1 gene, its expression, and the existence of an alternative splicing event. Nucleotide sequence analysis of the human and mouse OSF2/CBFA1 cDNAs showed a 98% homology in the coding sequence and 96% in the 5' untranslated (UTR) sequence. Analysis of CBFA1 genomic clones revealed that the 5' UTR sequence of the human OSF2/CBFA1 cDNA lies 75 kb upstream of the originally described 5' end of the gene. The existence of two OSF2/CBFA1 cDNAs is due to an alternative splicing event around exon 8 that affects the transcriptional activity of the protein. Northern blot analysis demonstrates that the expression of the human OSF2/CBFA1 gene is restricted to osteoblastic cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9434946     DOI: 10.1007/s003359900679

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  16 in total

1.  Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFalpha gene family.

Authors:  M Y Ahn; S C Bae; M Maruyama; Y Ito
Journal:  Gene       Date:  1996-02-12       Impact factor: 3.688

2.  Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.

Authors:  S Mundlos; F Otto; C Mundlos; J B Mulliken; A S Aylsworth; S Albright; D Lindhout; W G Cole; W Henn; J H Knoll; M J Owen; R Mertelsmann; B U Zabel; B R Olsen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

3.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

4.  Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.

Authors:  P Ducy; R Zhang; V Geoffroy; A L Ridall; G Karsenty
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Authors:  F Otto; A P Thornell; T Crompton; A Denzel; K C Gilmour; I R Rosewell; G W Stamp; R S Beddington; S Mundlos; B R Olsen; P B Selby; M J Owen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

6.  AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization.

Authors:  D Levanon; V Negreanu; Y Bernstein; I Bar-Am; L Avivi; Y Groner
Journal:  Genomics       Date:  1994-09-15       Impact factor: 5.736

7.  Identification and characterization of transcriptional arrest sites in exon 1 of the human adenosine deaminase gene.

Authors:  Z Chen; M L Harless; D A Wright; R E Kellems
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

8.  Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family.

Authors:  S Mundlos; J B Mulliken; D L Abramson; M L Warman; J H Knoll; B R Olsen
Journal:  Hum Mol Genet       Date:  1995-01       Impact factor: 6.150

9.  Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35-pter.

Authors:  C Wijmenga; N A Speck; N C Dracopoli; M H Hofker; P Liu; F S Collins
Journal:  Genomics       Date:  1995-04-10       Impact factor: 5.736

10.  Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain.

Authors:  S C Bae; E Takahashi; Y W Zhang; E Ogawa; K Shigesada; Y Namba; M Satake; Y Ito
Journal:  Gene       Date:  1995-07-04       Impact factor: 3.688

View more
  18 in total

Review 1.  Transcription factor Runx2 and its application to bone tissue engineering.

Authors:  Luca Dalle Carbonare; Giulio Innamorati; Maria Teresa Valenti
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Common polymorphisms rather than rare genetic variants of the Runx2 gene are associated with femoral neck BMD in Spanish women.

Authors:  Begoña Pineda; Carlos Hermenegildo; Paz Laporta; Juan J Tarín; Antonio Cano; Miguel Ángel García-Pérez
Journal:  J Bone Miner Metab       Date:  2010-04-21       Impact factor: 2.626

3.  RUNX2 mutations in Chinese patients with cleidocranial dysplasia.

Authors:  Yalin Li; Wei Pan; Wanfeng Xu; Nan He; Xuewu Chen; Hong Liu; L Darryl Quarles; Honghao Zhou; Zhousheng Xiao
Journal:  Mutagenesis       Date:  2009-06-10       Impact factor: 3.000

4.  A novel small deletion mutation in RUNX2 gene in one Chinese family with cleidocranial dysplasia.

Authors:  Ting Chen; Jin Hou; Ling-Ling Hu; Jie Gao; Bu-Ling Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

5.  Intragenic microdeletion of RUNX2 is a novel mechanism for cleidocranial dysplasia.

Authors:  Ming Ta Michael Lee; Anne Chun-Hui Tsai; Ching-Heng Chou; Feng-Mei Sun; Li-Chen Huang; Pauline Yen; Chyi-Chyang Lin; Chih-Yang Liu; Jer-Yuarn Wu; Yuan-Tsong Chen; Fuu-Jen Tsai
Journal:  Genomic Med       Date:  2008-08-12

Review 6.  Runx3 knockouts and stomach cancer.

Authors:  Ditsa Levanon; Ori Brenner; Florian Otto; Yoram Groner
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

7.  Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene.

Authors:  Mohammad Q Hassan; Amjad Javed; Maria I Morasso; Jeremy Karlin; Martin Montecino; Andre J van Wijnen; Gary S Stein; Janet L Stein; Jane B Lian
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation.

Authors:  Ofer Fainaru; Eilon Woolf; Joseph Lotem; Merav Yarmus; Ori Brenner; Dalia Goldenberg; Varda Negreanu; Yael Bernstein; Ditsa Levanon; Steffen Jung; Yoram Groner
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

Review 9.  Post-translational Regulation of Runx2 in Bone and Cartilage.

Authors:  J H Jonason; G Xiao; M Zhang; L Xing; D Chen
Journal:  J Dent Res       Date:  2009-08       Impact factor: 6.116

10.  Initial Characterization of Osteoblast Differentiation and Loss of RUNX2 Stability in the Newly Established SK11 Human Embryonic Stem Cell-Derived Cell Line.

Authors:  Jia-Li Yu; Helty Adisetiyo; Gillian H Little; C Thomas Vangsness; Jianjie Jiang; Hal Sternberg; Michael D West; Baruch Frenkel
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.